Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis—systematic review protocol

BACKGROUND: Erythema migrans represents an early cutaneous and most common manifestation of Lyme borreliosis. Recommendations regarding pharmacological agents, dose and duration of treatment are subject of intense debate. This review aims to explore differences in efficacy and safety between pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Torbahn, Gabriel, Hofmann, Heidelore, Allert, Roman, Freitag, Michael H., Dersch, Rick, Fingerle, Volker, Sommer, Harriet, Motschall, Edith, Meerpohl, Jörg J., Schmucker, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855495/
https://www.ncbi.nlm.nih.gov/pubmed/27142846
http://dx.doi.org/10.1186/s13643-016-0251-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855495/
https://www.ncbi.nlm.nih.gov/pubmed/27142846
http://dx.doi.org/10.1186/s13643-016-0251-3

Ejemplares similares